About
Cell Therapy
COVID-19
CLINICAL TRIALS
- NK CELL (MAGICELL-NK)
- OBP-301 (Telomelysin)
NEWS
Investors
Language

Corporate Regulations

Home | Corporate Regulations

Articles of Incorporation

Procedures for Election of Directors

Rules of Procedure for Shareholder Meetings

14F., No.3, Park St., Nangang Dist., Taipei City 11503, Taiwan (R.O.C)‧Copyright© 2021 Medigen Biotechnology Corp. All rights reserved.